The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a trial evaluating the safety of the agent in patients with ...

UCLA genetic scientists are reawakening hibernating follicles. A UCLA-discovered molecule, PP405, may finally offer real hope ...

Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of ...

Immatics' lead asset, IMA203, shows promising early data with a 57% ORR in heavily pretreated patients, but toxicity concerns ...

Aura Biosciences (AURA) has reported its Q4 and full-year 2024 financial results, prompting an ongoing decline in shares ...

As of December 31, 2024, Aura had cash and cash equivalents and marketable securities totaling $151.1 million. The Company believes its current cash and cash equivalents and marketable securities are ...

If you were asked to name the top cancers that affect women, breast cancer is sure to be among the first, perhaps with colon ...

TIL therapy is FDA-approved as a second or third option for patients with advanced melanoma. Gibney said in the future, the ...

If a person with the BRAF gene mutation has melanoma, knowing about the mutation is of great benefit for treatment because healthcare providers can use targeted therapy to inhibit the BRAF gene ...

March 15 — and got real about the extreme ups and downs of her cancer treatment. “I know I speak a lot about all the fun and amazing things that I’ve been doing since all of the tumors ...

Because nodular melanoma tends to grow aggressively, it is important to get this type of skin cancer diagnosed early so treatment can begin as soon as possible. A doctor may use a number of tests to ...

In Saskatchewan, a group of dedicated oncology nurses have stepped up to address this overlooked aspect of cancer treatment by creating the Prairie Cancer Fertility Preservation (PCFP) fund. Formed in ...